Tower Research Capital LLC (Trc) Acelrx Pharmaceuticals Inc Transaction History

Tower Research Capital LLC (Trc)

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 10, 2022	BUY	$0.2 - $0.35 $1,664 - $2,913	8,324 Added 21.8%	46,511 $10,000
Q2 2022 Aug 15, 2022	BUY	$0.18 - $0.29 $1,129 - $1,819	6,275 Added 19.66%	38,187 $9,000
Q1 2022 May 12, 2022	BUY	$0.28 - $0.61 $5,458 - $11,891	19,494 Added 156.98%	31,912 $9,000
Q4 2021 Feb 14, 2022	BUY	$0.49 - $1.02 $6,084 - $12,666	12,418 New	12,418 $7,000
Q3 2021 Nov 15, 2021	SELL	$0.93 - $1.51 $886 - $1,439	-953 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$1.03 - $1.7 $6,341 - $10,466	-6,157 Reduced 86.6%	953 $1,000
Q1 2021 May 17, 2021	SELL	$1.25 - $2.77 $19,783 - $43,840	-15,827 Reduced 69.0%	7,110 $12,000
Q4 2020 Feb 16, 2021	SELL	$1.18 - $1.98 $79,937 - $134,133	-67,744 Reduced 74.71%	22,937 $28,000
Q3 2020 Nov 16, 2020	BUY	$1.01 - $1.81 $55,982 - $100,324	55,428 Added 157.23%	90,681 $129,000
Q2 2020 Aug 13, 2020	BUY	$1.03 - $1.69 $32,159 - $52,766	31,223 Added 774.76%	35,253 $43,000
Q1 2020 May 15, 2020	BUY	$0.76 - $2.07 $1,040 - $2,833	1,369 Added 51.45%	4,030 $5,000
Q4 2019 Feb 07, 2020	SELL	$1.66 - $2.4 $5,267 - $7,615	-3,173 Reduced 54.39%	2,661 $6,000
Q3 2019 Nov 05, 2019	BUY	$2.1 - $2.87 $6,793 - $9,284	3,235 Added 124.47%	5,834 $13,000
Q2 2019 Aug 13, 2019	SELL	$2.1 - $3.93 $285 - $534	-136 Reduced 4.97%	2,599 $7,000
Q1 2019 May 14, 2019	SELL	$2.35 - $3.83 $5,748 - $9,368	-2,446 Reduced 47.21%	2,735 $10,000
Q4 2018 Feb 14, 2019	BUY	$2.13 - $4.8 $11,035 - $24,868	5,181 New	5,181 $12,000

Ticker ACRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 7,366,600
Market Cap $8.32M
Description
AcelRx Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of therapies for the treatment of acute pain. Its lead product candidate is DSUVIA and DZUVEO, a 30 mcg sufentanil sublingual tablet for the treatment of moderate-to-severe acute pain. The company develops ZALVISO, a pre-programmed ...

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.